Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Neisseria meningitidis ST-11 Clonal Complex, Chile 2012
Filetype[PDF-378.09 KB]


Details:
No Related Documents.
You May Also Like:
  1. Effectiveness of Meningococcal B Vaccine against Endemic Hypervirulent Neisseriameningitidis W Strain, England
    Personal Author:
    Ladhani, Shamez N.; Giuliani, Marzia Monica; Biolchi, Alessia; Pizza, Mariagrazia; Beebeejaun, Kazim; Lucidarme, Jay; Findlow, Jamie; Ramsay, Mary E.; Borrow, Ray;
    Published Date:
    Feb 2016
    Source:
    Emerg Infect Dis. 22(2):309-311.
    Description:
    Serum samples from children immunized with a meningococcal serogroup B vaccine demonstrated potent serum bactericidal antibody activity against the hypervirulent Neisseria meningitidis serogroup W strain circulating in England. The recent introductio...
    File Type:
    Filetype[PDF - 321.21 KB]
  2. Increase in Meningococcal Serogroup W Disease, Victoria, Australia, 2013–2015
    Personal Author:
    Carville, Kylie S.; Stevens, Kerrie; Sohail, Asma; Franklin, Lucinda J.; Bond, Katherine A.; Brahmi, Aicha; Romanes, Finn; Ong, Katherine S.;
    Published Date:
    Oct 2016
    Source:
    Emerg Infect Dis. 22(10):1785-1787.
    Description:
    In Victoria, Australia, invasive meningococcal disease caused by Neisseria meningitidis serogroup W increased from 4% of all cases in 2013 to 30% in 2015. This increase resulted largely from strains similar to those in the serogroup W sequence type 1...
    File Type:
    Filetype[PDF - 717.83 KB]
  3. Population structure of invasive Neisseria meningitidis in the United States, 2011–15☆
    Personal Author:
    Potts, Caelin C.; Joseph, Sandeep j.; Chang, How-Yi; Chen, Alexander; Vuong, jeni; Hu, Fang; jenkins, Laurel T.; Schmink, Susanna; Blain, Amy; MacNeil, Jessica R.; Harrison, Lee H.; Wang, Xin;
    Published Date:
    June 30 2018
    Source:
    J Infect. 77(5):427-434
    Description:
    Objectives:Meningococcal conjugate vaccines (MenACWY) were licensed in the United States in 2005. We assessed the population structure of invasive Neisseria meningitidis (Nm) ten years after recommended use of MenACWY among adolescents.Methods:Mening...
    File Type:
    Filetype[PDF - 1.11 MB]
  4. The Establishment and Diversification of Epidemic-Associated Serogroup W Meningococcus in the African Meningitis Belt, 1994 to 2012
    Personal Author:
    Retchless, Adam C.; Hu, Fang; Ouédraogo, Abdoul-Salam; Diarra, Seydou; Knipe, Kristen; Sheth, Mili; Rowe, Lori A.; Sangaré, Lassana; Ky Ba, Absetou; Ouangraoua, Soumeya; Batra, Dhwani; Novak, Ryan T.; Ouédraogo Traoré, Rasmata; Wang, Xin;
    Published Date:
    2016 Nov-Dec
    Source:
    mSphere. 2016; 1(6).
    Description:
    Epidemics of invasive meningococcal disease (IMD) caused by meningococcal serogroup A have been eliminated from the sub-Saharan African so-called "meningitis belt" by the meningococcal A conjugate vaccine (MACV), and yet, other serogroups continue to...
    File Type:
    Filetype[PDF - 410.71 KB]
  5. Case Manifestations and Public Health Response for Outbreak of Meningococcal W Disease, Central Australia, 2017
    Personal Author:
    Sudbury, Eva L.; O’Sullivan, Siobhan; Lister, David; Varghese, Deepa; Satharasinghe, Keshan;
    Published Date:
    Jul 2020
    Source:
    Emerg Infect Dis. 26(7):1355-1363
    Description:
    Neisseria meningitidis serogroup W has emerged as an increasingly common cause of invasive meningococcal disease worldwide; the average case-fatality rate is 10%. In 2017, an unprecedented outbreak of serogroup W infection occurred among the Indigeno...
    File Type:
    Filetype[PDF - 1.12 MB]